For R&D use only.

Methyl 3-bromo-5-hydroxybenzoate

  • Catalog NO.:A880305
  • CAS No. : 192810-12-1
  • Molecular Formula:C8H7BrO3
  • Molecular Weight: 231.04
Note*
1. Please click the  to confirm the discount and stock quantity.
2. Click“Bulk Inquiry”to ask for quotations of other quantity.
3. The price does not include shipping and bank charges.
Bulk Inquiry
Quality Control&SDS
SDS COA

Product Details

CAS Number 192810-12-1 Appearance Yellow powder
Catalog Number A880305 MDL Number MFCD10566800
Molecular Formula C8H7BrO3 Molecular Weight 231.04
Boiling Point Melting Point 130-135°C
Flash Point Density
Synonyms Methyl 3-bromo-5-hydroxybenzoate
Storage Condition Store in a tightly closed container,in a cool and dry place

Safety

GHS Pictogram
Signal Word Warning UN Number
Hazard Statements H315; H319; H335 Class
Precautionary Statements P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501 Packing Group

Description

Nintedanib, also known as BIBF1120, is a potent inhibitor of multiple receptor tyrosine kinases (RTKs) and non-receptor tyrosine kinases (nRTKs). Nintedanib inhibits the following RTKs: platelet-derived growth factor receptor (PDGFR) α and β, fibroblast growth factor receptor (FGFR) 1-3, vascular endothelial growth factor receptor (VEGFR) 1-3, and Fms-like tyrosine kinase-3 (FLT3). Nintedanib binds competitively to the adenosine triphosphate (ATP) binding pocket of these receptors and blocks the intracellular signaling which is crucial for the proliferation, migration, and transformation of fibroblasts representing essential mechanisms of the IPF pathology. Nintedanib esylate was approved in 2014 for the treatment of idiopathic pulmonary fibrosis (IPF).

656247-18-6 (esylate)

656247-17-5 (free base)

928326-83-4 (free base)

Related Products

Batch search Close
Batch processing can be done by CAS number, CAS number, one search per line
...

Methyl 3-bromo-5-hydroxybenzoate
Methyl 3-bromo-5-hydroxybenzoate